Abstract
Aim:
To construct a recombinant adeno-associated virus (rAAV) vector containing gene encoding phospholamban antisense RNA (asPLB), and analyse its effect on expression of PLB, expression and activity of sarco-endoplasmic reticulum Ca2+-ATPase (SERCA), and the change of intracellular free Ca2+ concentration ([Ca2+]i) in rat cardiomyocytes.
Methods:
The target gene encoding PLB antisense RNA was inserted inversely into the adeno-associated virus plasmid pAAV-MCS digested by corresponding restricted endonuclease enzyme. The recombinant plasmid and pAAV-RC and pHelper were co-transfected into 293 cell. At the same time, a viral production positive control (rAAV-LacZ) and negative control were performed. The recombinant viruses were used to transfect the cultured rat cardiomyocytes. Site β-Galactosidase staining were performed to observe the transfer efficiency. Reverse transcription-PCR and Western blot were used to determine the mRNA and protein expression of PLB and SERCA. The activity of SERCA and the [Ca2+]i were measured.
Results:
The rAAV vectors were constructed successfully and were transfected into rat cardiomyocytes effectively. The PLB mRNA and protein expression were reduced in rat cardiomyocytes transfected by rAAV-asPLB compared with controls. The activity of SERCA was increased. In rest state, the level of [Ca2+]i in the rAAV-asPLB transfected group decreased. The level of [Ca2+]i increased when induced by isoproterenol.
Conclusion:
AAV-asPLB vector was constructed successfully, which disrupted the expression of PLB, enhanced the activity of SERCA, reduced the resting [Ca2+]i, and improved the cardiac function.
Similar content being viewed by others
Article PDF
References
Bernecker OY, del Monte F, Hajjar RJ . Gene therapy for the treatment of heart failure-calcium signaling. Semin Thorac Cardiovasc Surg 2003; 15: 268–76.
Zhai J, Schmidt AG, Hoit BD, Kimura Y, MacLennan DH, Kranias EG . Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem 2000; 275 (14): 10538–44.
Koss KL, Grupp IL, Kranias EG . The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility. Basic Res Cardiol 1997; 92 ( Suppl 1): 17–24.
Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 1994; 75: 401–9.
Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW, Walsh RA, et al. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocytes mechanics in transgenic mice. J Clin Invest 1996; 97: 533–9.
He H, Meyer M, Martin JL, McDonough PM, Ho P, Lou X, et al. Effects of mutant and antisense RNA of phospholamban on SR Ca2+-ATPase activity and cardiac myocyte contractility. Circulation 1999; 100: 974–80.
Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ . Targeting phospholamban by gene transfer in human heart failure. Circulation 2002; 105: 904–7.
Clark KP, Voulgaropoulou F, Johnson P R . A stable cell line carrying adenovirus-inducible rep and cap genes allow for infectivity titration of adeno-associated virus vectors. Gene Ther 1996; 3: 1124–32.
Zhang YB, Leng XS, Peng JR, He XJ, LU JF, Weng SG, et al. Construction, packaging, and titration of recombinant adeno-association virus vectors contaning antitumor genes. Natl Med J China 2002; 82: 564–7.
Svensson EC, Marshall DJ, Woodard K, Lin H, Jing F, Chu L, et al. Efficient and stable transduction of cardiomyocytes after intramyocardiol injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 1999; 99: 201–5.
Larsen JS, Kjeldsen K . Quantification in crude homogenates of rat myocardial Na+, K+- and Ca2+-ATPase by K+ and Ca2+-dependent pNPPase age-dependent changes. Basic Res Cardiol 1995; 90: 323–31.
Qiao GF, Zhou H, Li BY . Antagonistic effects of berbamine on [Ca2+]i mobilization by KCl, norepinephrine, and caffeine in newborn rat cardiomyocytes. Acta Pharmacol Sin 1999; 20: 292–6.
Brittsan AG, Kranias EG . Phospholamban and cardiac contractile function. J Mol Cell Cardiol 2000; 32: 2131–9.
Teramoto S, Ishii T, Matsuse T, Fukuchi Y . Recombinant adeno-associated virus vectors efficiently transduce foreign gene into bovine aortic endothelial cell: comparison with adenovirus vectors. Jpn J Pharmacol 2000; 84: 206–12.
Wang L, Zhang GM, Feng ZH . Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line. Acta Pharmacol Sin 2003; 24: 1235–40.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Scientific and Technological Agency of Zhejiang Province (No 021107817).
Rights and permissions
About this article
Cite this article
Li, J., Hu, Sj., Sun, J. et al. Construction of phospholamban antisense RNA recombinant adeno-associated virus vector and its effects in rat cardiomyocytes. Acta Pharmacol Sin 26, 51–55 (2005). https://doi.org/10.1111/j.1745-7254.2005.00006.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00006.x
Keywords
This article is cited by
-
AAV Vectors for Cardiac Gene Transfer: Experimental Tools and Clinical Opportunities
Molecular Therapy (2011)
-
Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban
Gene Therapy (2007)
-
rAAV-mediated angiogenin gene transfer induces angiogenesis and modifies left ventricular remodeling in rats with myocardial infarction
Journal of Molecular Medicine (2006)
-
SERCA2a in Heart Failure: Role and Therapeutic Prospects
Journal of Bioenergetics and Biomembranes (2005)